Roche’s Virtual Event following Angiogenesis 2021

Agenda:

Welcome

Ophthalmology Strategy Update

Ophthalmology Pipeline Update

Faricimab in DME and nAMD – Phase III results

Q&A

Karl Mahler, Head of Investor Relations and Roche Group Planning

Atul Dandekar, Vice President and Global Franchise Head of Ophthalmology Product Strategy

Christopher Brittain, Vice President and Global Head of Ophthalmology Product Development

Nancy Holekamp, M.D., Retina Specialist and Clinical Investigator

Please register to access the replay*

First Name

Last name

Corporate Email

Company Name

Confirm you are a human *

Roche has hosted a virtual event on Tuesday, 16th February 2021.

Investors

Downloads

PDF